China Zhong Qi Hldgs EV / EBITDA
Cos'è EV / EBITDA di China Zhong Qi Hldgs?
EV / EBITDA di China Zhong Qi Hldgs Ltd. è 0.36
Qual è la definizione di EV / EBITDA?
EV / EBITDA è il valore aziendale diviso per guadagni prima di interessi, tasse, deprezzamento e ammortamento. È una misura di quanto sia costosa una azione ed è più frequentemente valida per i confronti tra le aziende rispetto al rapporto prezzo / guadagno. Misura il prezzo (sotto forma di valore d'impresa) che un investitore paga a vantaggio del flusso di cassa della società (sotto forma di EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA di aziende nel Materials settore su OTC rispetto a China Zhong Qi Hldgs
Cosa fa China Zhong Qi Hldgs?
024 Pharma, Inc. provides healthcare products worldwide. Its products include vitamin and mineral supplements; stress release, joint, heart health, and weight-loss products; and skin care, hair, and anti-aging products. The company was formerly known as B Green Innovations, Inc. and changed its name to 024 Pharma, Inc. in October 2016. 024 Pharma, Inc. was incorporated in 2004 and is based in West Palm Beach, Florida.
Aziende con ev / ebitda simili a China Zhong Qi Hldgs
- Aprea Therapeutics ha EV / EBITDA di 0.34
- Sing Tao News ha EV / EBITDA di 0.35
- Vergnet SA ha EV / EBITDA di 0.35
- Phimedix Plc ha EV / EBITDA di 0.35
- Boomer ha EV / EBITDA di 0.35
- Esso ha EV / EBITDA di 0.35
- China Zhong Qi Hldgs ha EV / EBITDA di 0.36
- Hoth Therapeutics ha EV / EBITDA di 0.36
- Cara Therapeutics Inc ha EV / EBITDA di 0.37
- Kubient ha EV / EBITDA di 0.37
- Virgin Galactic Inc ha EV / EBITDA di 0.37
- Clover Health Investments Corp ha EV / EBITDA di 0.38
- Ennox Ltd ha EV / EBITDA di 0.38